Harvard Bioscience reduces stockholder meeting quorum to one-third of shares

HARVARD BIOSCIENCE INC

Board approved amendment reducing quorum requirement for stockholder meetings from a majority to one-third of voting shares.
Amendment effective January 19, 2026, upon Board adoption; filed as Exhibit 3.1.
No other changes to bylaws disclosed in the filing.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

HARVARD BIOSCIENCE INC: Reduced quorum requirement for stockholder meetings from a majority to one-third of shares entitled to vote (effective 2026-01-19).

Change: bylaw amendment
Effective: 2026-01-19

Exact text from the filing

On January 19, 2026, the Board of Directors (the “Board”) of Harvard Bioscience, Inc., a Delaware corporation (the “Company”), approved an amendment to the Company’s Amended and Restated By-laws to reduce the quorum requirement for stockholder meetings from a majority to one-third (1/3) of the shares of capital stock entitled to vote (the “By-laws Amendment”).

View on SEC.gov

Browse all governance changes →

HARVARD BIOSCIENCE INC filing history →

Source: SEC EDGAR

accession 0001171843-26-000343

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.